Search hospitals > Florida > Orlando
Orlando Health Cancer Institute
Claim this profileOrlando, Florida 32806
Global Leader in Thyroid Cancer
Global Leader in Breast Cancer
Conducts research for Skin Cancer
Conducts research for Uterine Tumors
Conducts research for Lung Cancer
239 reported clinical trials
23 medical researchers
Summary
Orlando Health Cancer Institute is a medical facility located in Orlando, Florida. This center is recognized for care of Thyroid Cancer, Breast Cancer, Skin Cancer, Uterine Tumors, Lung Cancer and other specialties. Orlando Health Cancer Institute is involved with conducting 239 clinical trials across 378 conditions. There are 23 research doctors associated with this hospital, such as Amy Smith, MD, Sajeve S. Thomas, Jennifer Tseng, MD, and Omar R. Kayaleh.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Amy Smith, MDArnold Palmer Hospital for Children7 years of reported clinical research
Expert in Uterine Tumors
Expert in Cancer
54 reported clinical trials
107 drugs studied
Sajeve S. ThomasOrlando Health Cancer Institute8 years of reported clinical research
Expert in Skin Cancer
Studies Melanoma
20 reported clinical trials
31 drugs studied
Jennifer Tseng, MDOrlando Health Cancer Institute10 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
30 drugs studied
Omar R. KayalehOrlando Health Cancer Institute5 years of reported clinical research
Studies Stomach Cancer
Studies Colorectal Cancer
6 reported clinical trials
23 drugs studied
Clinical Trials running at Orlando Health Cancer Institute
Breast Cancer
Lung Cancer
Skin Cancer
Esophageal Adenocarcinoma
Esophageal Carcinoma
Non-Small Cell Lung Cancer
Ovarian Cancer
Gastroesophageal Junction Adenocarcinoma
Bladder Cancer
Squamous Cell Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Sacituzumab Tirumotecan + Pembrolizumab
for Breast Cancer
The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent central review (BICR) in all participants.
Recruiting2 awards Phase 33 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Orlando Health Cancer Institute?
Orlando Health Cancer Institute is a medical facility located in Orlando, Florida. This center is recognized for care of Thyroid Cancer, Breast Cancer, Skin Cancer, Uterine Tumors, Lung Cancer and other specialties. Orlando Health Cancer Institute is involved with conducting 239 clinical trials across 378 conditions. There are 23 research doctors associated with this hospital, such as Amy Smith, MD, Sajeve S. Thomas, Jennifer Tseng, MD, and Omar R. Kayaleh.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.